- Long-Term Support: $64
- Long-Term Resistance: $103.87
- Swing Support: $82.51
- Swing Resistance: $94.39
Karyopharm Shares Fall After Selinexor Data In Endometrial Cancer Patients
Karyopharm Therapeutics Inc's (NASDAQ: KPTI) Phase 3 SIENDO selinexor study has